Clinical Observation of Shengxiantang in Treatment of Early Parkinson's Disease with Autonomic Dysfunction of Qi Deficiency Pattern

LU Zhengyu; ZHANG Qianru; PAN Luqian; LU Lingdan; ZHU Dongyu; ZHANG Hongjing; ZHAO Hong

doi:10.13422/j.cnki.syfjx.20221826

您当前的位置：

首页 >

文章列表页 >

Clinical Observation of Shengxiantang in Treatment of Early Parkinson's Disease with Autonomic Dysfunction of Qi Deficiency Pattern

更新时间：2022-12-21

- Clinical Observation of Shengxiantang in Treatment of Early Parkinson's Disease with Autonomic Dysfunction of Qi Deficiency Pattern
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 2, Pages: 119-124(2023)
- 作者机构：
  
  1.上海中医药大学附属岳阳中西医结合医院，上海 200437
  2.上海中医药大学附属龙华医院，上海 200032
  3.莱芜职业技术学校，山东莱芜 250000
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20221826
  CLC： R22;R242;R2-031;R287
- Received：19 April 2022，
  
  Published Online：01 July 2022，
  
  Published：20 January 2023
- 稿件说明：
移动端阅览
陆征宇,张倩茹,潘露茜等.升陷汤治疗气虚型早期帕金森病自主神经功能障碍的临床观察[J].中国实验方剂学杂志,2023,29(02):119-124.

LU Zhengyu,ZHANG Qianru,PAN Luqian,et al.Clinical Observation of Shengxiantang in Treatment of Early Parkinson's Disease with Autonomic Dysfunction of Qi Deficiency Pattern[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(02):119-124.
陆征宇,张倩茹,潘露茜等.升陷汤治疗气虚型早期帕金森病自主神经功能障碍的临床观察[J].中国实验方剂学杂志,2023,29(02):119-124. DOI： 10.13422/j.cnki.syfjx.20221826.

LU Zhengyu,ZHANG Qianru,PAN Luqian,et al.Clinical Observation of Shengxiantang in Treatment of Early Parkinson's Disease with Autonomic Dysfunction of Qi Deficiency Pattern[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(02):119-124. DOI： 10.13422/j.cnki.syfjx.20221826.

摘要

目的

研究升陷汤治疗气虚型早期帕金森病自主神经功能障碍的安全性和有效性。

方法

将82例符合纳入标准的患者随机分为对照组和中药组，各41例，在西医规范化治疗基础上，中药组加用升陷汤，对照组加用安慰剂，连续治疗12周。治疗前后分别采用帕金森病自主神经功能评定量表、帕金森病统一评分量表、帕金森病中医气虚症状评分评估临床疗效，并对血清谷胱甘肽过氧化物酶和血清超氧化物歧化酶水平、每日普拉克索和多巴丝肼用量及安全性指标进行检测、评估。

结果

与本组治疗前比较，治疗后对照组帕金森病自主神经功能评定量表总分、消化系统症状评分、泌尿系统症状评分和体温调节功能评分显著升高（

0.01），中药组帕金森病自主神经功能评定量表总分、消化系统症状评分、泌尿系统症状评分和体温调节功能评分明显降低（

0.05，

0.01），两组心血管系统症状评分、瞳孔调节功能评分、性功能评分无意义；治疗后与对照组比较，中药组帕金森病自主神经功能评定量表总分、消化系统症状评分、泌尿系统症状评分和体温调节功能评分明显降低（

0.05，

0.01），心血管系统症状评分、瞳孔调节功能评分、性功能评分差异无统计学意义。与本组治疗前比较，治疗后对照组帕金森病中医气虚症状评分总分、主证评分、次证评分无意义，中药组帕金森病中医气虚症状评分总分、次证评分降低（

0.01），中药组主证评分差异无统计学意义。与本组治疗前比较，两组帕金森病统一评分量表积分、血清谷胱甘肽过氧化物酶和超氧化物歧化酶水平、普拉克索和多巴丝肼每日用量差异无统计学意义；治疗后与对照组比较，中药组帕金森病统一评分量表积分、血清谷胱甘肽过氧化物酶和超氧化物歧化酶水平、普拉克索和多巴丝肼每日用量差异无统计学意义。安全性指标未见异常。

结论

在西医规范化治疗基础上，给予升陷汤治疗可以有效改善气虚型早期帕金森病自主神经功能障碍患者的消化系统、泌尿系统和体温调节等自主神经症状及气虚症状，且具有良好的安全性。

Abstract

Objective

To investigate the efficacy and safety of Shengxiantang in the treatment of early Parkinson's disease with autonomic dysfunction of Qi deficiency pattern.

Method

A total of 82 eligible patients were randomized into control group （41 cases） and traditional Chinese medicine （TCM） group （41 cases）. On the basis of standardized treatment of western medicine， TCM group was prescribed Shengxiantang while control group were treated with placebo for 12 consecutive weeks additionally. Scale for Outcomes in Parkinson's Disease-Autonomic （SCOPA-AUT） questionnaire， Unified Parkinson's Disease Rating Scale （UPDRS）， Traditional Chinese Medicine Qi Deficiency Symptom Score of Parkinson's Disease （TCMQDSSPD）， serum levels of glutathione peroxidase （GPx） and superoxide dismutase （SOD）， daily dosage of pramipexole and levodopa and benserazide hydrochloride， and safety index were evaluated both before and after treatment.

Result

After treatment， the total score of SCOPA-AUT， gastrointestinal score， urinary score， and thermoregulatory score in the control group were higher than those before treatment （

0.01）， while the above sores in the TCM group were lower than those before treatment （

0.05，

0.01）. In addition， the cardiovascular score， pupillomotor score， and sexual score in two groups showed no significant difference from those before treatment. After treatment， the total score of SCOPA-AUT， gastrointestinal score， urinary score， and thermoregulatory score in the TCM group were lower than those in the control group （

0.05，

0.01）， and cardiovascular score， pupillomotor score， and sexual score showed no significant difference between two groups. After treatment， the total score of TCMQDSSPD， main symptom scores， and minor symptom scores in the control group had no significant difference from those before treatment. The total score of TCMQDSSPD and minor symptom scores of TCM group were lower than those before treatment （

0.01）， while the main symptom scores of the TCM group showed no significant difference from those before treatment. After treatment， the UPDRS score， serum GPx and SOD levels， and daily dosage of pramipexole and levodopa and benserazide hydrochloride demonstrated no significant difference from those before treatment in the two groups and between the two groups. No abnormality was found in the safety indexes.

Conclusion

Based on the standardized treatment of western medicine， Shengxiantang can effectively and safely improve the autonomic symptoms of gastrointestinal system， urinary system， and thermoregulation， as well as the symptoms of Qi deficiency syndrome in early Parkinson's disease with autonomic dysfunction.

关键词

Keywords

references

SCHAPIRA A H V ， CHAUDHURI K R ， JENNER P . Non-motor features of Parkinson disease ［J］. Nat Rev Neurosci ， 2017 ， 18 （ 7 ）： 435 - 450 .

CHEN Z ， LI G ， LIU J . Autonomic dysfunction in Parkinson's disease： Implications for pathophysiology， diagnosis， and treatment ［J］. Neurobiol Dis ， 2020 ， doi： 10.1016/j.nbd.2019.104700 http://dx.doi.org/10.1016/j.nbd.2019.104700 .

BANG Y ， LIM J ， CHOI H J . Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease： Clues to early diagnosis and effective treatment ［J］. Arch Pharm Res ， 2021 ， 44 （ 6 ）： 588 - 604 .

LIU R ， UMBACH D M ， TRÖSTER A I ， et al . Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease ［J］. Parkinsonism Relat Disord ， 2020 ， doi： 10.1016/j.parkreldis.2020.02.001 http://dx.doi.org/10.1016/j.parkreldis.2020.02.001 .

ARNAO V ， CINTURINO A ， VALENTINO F ， et al . In patient's with Parkinson disease， autonomic symptoms are frequent and associated with other non-motor symptoms ［J］. Clin Auton Res ， 2015 ， 25 （ 5 ）： 301 - 307 .

SEPPI K ， RAY CHAUDHURI K ， COELHO M ， et al . Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine ［J］. Mov Disord ， 2019 ， 34 （ 2 ）： 180 - 198 .

帕金森病自主神经功能障碍中西医结合诊治专家共识写作组．帕金森病自主神经功能障碍中西医结合诊治专家共识（2020）［J］．南京中医药大学学报， 2021 ， 37 （ 1 ）： 6 - 12 ．

陆征宇，赵虹，汪涛，等．补肾疏肝方药治疗肝肾阴虚型帕金森病伴发轻中度抑郁障碍［J］．中国实验方剂学杂志， 2013 ， 19 （ 24 ）： 324 - 328 ．

陆征宇，陆玲丹，朱冬雨，等．平颤益髓方治疗帕金森病髓海不足证合并轻度认知功能损伤的疗效研究［J］．北京中医药大学学报， 2017 ， 40 （ 5 ）： 436 - 440 ．

陆征宇，陆玲丹，朱冬雨，等．补肾填精方治疗髓海不足型帕金森病伴轻度认知功能障碍的临床研究［J］．中国中西医结合杂志， 2018 ， 38 （ 5 ）： 539 - 543 ．

HUGHES A J ， DANIEL S E ， KILFORD L ， et al . Accuracy of clinical diagnosis of idiopathic Parkinson's disease： A clinico-pathological study of 100 cases ［J］. J Neurol Neurosurg Psychiatry ， 1992 ， 55 （ 3 ）： 181 - 184 .

中华医学会神经病学分会帕金森病及运动障碍学组，中国医师协会神经内科医师分会帕金森病及运动障碍专业委员会．中国帕金森病的诊断标准（2016版）［J］．中华神经科杂志， 2016 ， 49 （ 4 ）： 268 - 217 ．

中华医学会神经病学分会帕金森病及运动障碍学组．中国帕金森病治疗指南（第三版）［J］．中华神经科杂志， 2014 ， 47 （ 6 ）： 428 - 433 ．

郑筱萸．中药新药临床研究指导原则（试行）［M］．北京：中国医药科技出版社， 2002 ： 379 ．

CHAUDHURI K R ， HEALY D G ， SCHAPIRA A H V ， et al . Non-motor symptoms of Parkinson's disease： Diagnosis and management ［J］. Lancet Neurol ， 2006 ， 5 （ 3 ）： 235 - 245 .

BRAAK H ， DEL TREDICI K ， RÜB U ， et al . Staging of brain pathology related to sporadic Parkinson's disease ［J］. Neurobiol Aging ， 2003 ， 24 （ 2 ）： 197 - 211 .

刘旺，赵虹，夏兆云，等．帕金森病相关病理演变研究进展［J］．神经损伤与功能重建， 2022 ， 17 （ 3 ）： 148 - 151 ．

VERBAAN D ， MARINUS J ， VISSER M ， et al . Patient-reported autonomic symptoms in Parkinson disease ［J］. Neurology ， 2007 ， 69 （ 4 ）： 333 - 341 .

中华中医药学会．中医内科常见病诊疗指南·中医病证部分［M］．北京：中国中医药出版社， 2008 ： 138 - 140 .

赵虹，李文伟，高俊鹏，等．补肾养肝方药治疗肝肾阴虚型帕金森病临床研究［J］．中国中西医结合杂志， 2007 ， 27 （ 9 ）： 780 - 784 ．

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Shengxiantang Alleviates Idiopathic Pulmonary Fibrosis in Rats by Regulating Oxidative Stress to Inhibit PANoptosis

DIA Proteomics Reveals Mechanism of Acanthopanacis Senticosi Radix et Rhizoma seu Caulis Extract in Treating α-Syn Transgenic Parkinson's Disease in Mice

Protective Effect of Shengxiantang on Myocardial Microvascular Injury in Rats with Chronic Heart Failure

Clinical Diseases Responding Specially to TCM Treatment： Psoriasis

Treatment of Parkinson's Disease with Traditional Chinese Medicine by Regulating BDNF/TrkB Signaling Pathway： A Review

Related Author

LIANG Yulei

YAN Yanan

LI Wei

LIU Na

FANG Chaoyi

WANG Jiepeng

ZHENG Qi

LU Yi

Related Institution

Hebei University of Chinese Medicine

Hebei Key Laboratory of Integrated Chinese and Western Medicine for Lung Disease Research

Institute of Traditional Chinese Medicine， Heilongjiang University of Chinese Medicine

Key Laboratory of Modern Preparation of Traditional Chinese Medicine，Ministry of Education，Jiangxi University of Chinese Medicine

Drug Safety Evaluation Centre，Heilongjiang University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰